Skip to main content

Flavored vaping rules

VDX Distro v. Food and Drug Administration

Updated Nov 20, 2026

In brief

Where it stands
Petition Pending

Awaiting an order on the petition

No decision timeline until the Court agrees to hear the case.

What it’s about
VDX Distro and Vapetastic ask the Supreme Court to review FDA’s condition requiring evidence comparing the effectiveness of non-tobacco-flavored vaping products; they argue FDA had to adopt it through public rulemaking.
What's at stake
The petition leaves unresolved whether FDA had to use public rulemaking for its condition and whether Congress could leave FDA to decide which other tobacco products to regulate.

Summary: written with AI from the case record.

What it's about

They also argue Congress unconstitutionally let FDA decide which other tobacco products to regulate.

The first issue resembles a question the Supreme Court left open in FDA v. Wages and White Lion Investments in 2025.

Question presented

1. Whether FDA’s uniform condition on the marketing of every non-tobacco-flavored vaping product — enforcement of a flavor-triggered comparative efficacy requirement — is a “tobacco product standard” for which the TCA § 387j required notice-and-comment rulemaking. This question parallels the one this Court left open in FDA v. Wages and White Lion Investments, L.L.C., 604 U.S. 542, 565 (2025). 2. Whether § 387a(b)’s “deeming” provision is unconstitutional because Article I, enforced through the major questions doctrine, required Congress to specifically decide which “other tobacco products” to regulate.

What happens next

The Court must decide whether to hear the petition. No oral argument or decision date is scheduled.

Documents

1

Docket activity

5
  • New analysis added

    Nov 20, 2026 · Court records

  • AI analysis generated: Case Briefing

    Nov 20, 2026 · Generated

  • Case data updated: summary, question_presented, generation_metadata

    Nov 20, 2026 · Court records

  • Case data updated: question_presented, extraction_metadata

    Nov 20, 2026 · Court records

  • Brief added: Petition

    Nov 17, 2026 · Court records

More questions

1
What legal issues does VDX raise?
VDX argues FDA had to use a public rulemaking process for its condition and that Congress could not leave FDA to choose which other tobacco products to regulate.

Sources

Primary materials plus reporting. Best-effort analysis: this explainer relies on a mix of primary materials and trusted secondary sources. Official filings and opinions remain authoritative.

Checked Nov 20, 2026Methodology

Court records and filings

Reporting and analysis